Side Effects of Drugs Annual 15/1991

A Yearly Critical Survey of the World's Literature on Adverse Reactions to Drugs

Edited by

  • M.N.G. Dukes
  • J.K. Aronson, MRC Unit and University Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford, United Kingdom

The expert team of authors and editors working on the series have once again critically reviewed the vast amount of data on adverse drug reactions appearing annually. The Side Effects of Drugs Annual provides a complete overview of all known side effects of drugs, both major and obscure.

The 'Special Reviews' give special attention to topics of current interest:

-Reye's syndrome and aspirin; better proof than before

-Doubts about midazolam

-Newer non-depolarizing neuromuscular blocking agents

-Contact allergy to corticosteroids

-Amiodarone and the lungs

-Sexual function and beta-blockade

-Antibiotic prescribers - when will they ever learn?

-Ceftriaxone - a wonder drug or a wolf in sheep's clothing?

-Post-marketing surveillance: where do we go and who will take us there?

-Chloramphenicol and predictability of toxicity in pediatric patients

-Aminoglycosides-induced renal damage

-Ribostamycin, aminoglycosides and cross-reactivity

-The place of chloroquine in malaria treatment

-Quinine versus quinidine

-Immunotherapy versus chemotherapy in leishmaniasis

-Safety and risks of enzyme inhibition

-Surveillance programs in immunization

-Diagnosing hypervitaminosis A

-Breast cancer and the pill: a still unproven risk?

-Human insulin and the risk of hypoglycemia

-Effect of somatostatin on glucose homeostasis and insulin secretion

-Serious risks in combining new lipid-lowering drugs

-L-tryptophan and the eosinophilia-myalgia syndrome

View full description


Book information

  • Published: December 1991
  • Imprint: ELSEVIER
  • ISBN: 978-0-444-89171-6

Table of Contents

Essay: The nocebo effect - poorly known but getting stronger (P. Tyrer). 1. Central nervous system stimulants and anorectic agents (R.P. Sequeira). 2. Antidepressant drugs (M. Elphick). 3. Lithium (M. Schou). 4. Drugs of abuse (A.I. Green, E.J. Watsky and C. Salzman). 5. Hypnotics and sedatives (T.C. Jerram). 6. Antipsychotic drugs (D. Capellà and J.-R. Laporte). 7. Anticonvulsant drugs (J.C. Mucklow). 8. Opioid analgesics and narcotic antagonists (A.H. Ghodse and A.K. Vohra). 9. Antipyretic analgesics (G. Agnelli and B. Cosmi). 10. Anti-inflammatory analgesics and drugs used in rheumatoid arthritis and gout (A. Del Favero). 11. General anesthetics and therapeutic gases (M.N.G. Dukes). 12. Local anesthetics (A. Chiffoleau and C. Larousse). 13. Neuromuscular blocking agents and skeletal muscle relaxants (F.J. Richardson and S. Agoston). 14. Drugs affecting autonomic functions or the extrapyramidal system (I. Lunde). 15. Dermatological drugs, topical agents and cosmetics (A.C. de Groot). 16. Antihistamines (I. Lunde). 17. Antiallergic and antitussive drugs (F.A. Nelemans). 18. Positive inotropic drugs and drugs used in dysrhythmias (J.K. Aronson). 19. &bgr;-Adrenoceptor and antianginal drugs (L. Offerhaus). 20. Drugs acting on the cerebral and peripheral circulation (R. Verhaeghe and M. Verstraete). 21. Antihypertensive drugs (J.A. Steiner). 22. Diuretic drugs (G.T. McInnes). 23. Metals (P.L.C.M. van Riel). 24. Metal antagonists (R.H.B. Meyboom and I.A. Jaffe). 25. Antiseptic drugs and disinfectants (G. Reybrouck). 26. Penicillins, cephalosporins and tetracyclines (T. Midtvedt). 27. Miscellaneous antibiotics (T. Midtvedt). 28. Antifungal drugs (V.K. Lephakhin and A.V. Astakhova).29. Antiprotozoal drugs (I. Nir). 30. Miscellaneous antibacterial and antiviral drugs (J.E. Idäanpään-Heikkilä and K.M. Aranko). 31. Drugs used in tuberculosis and leprosy (C.J. Ellis). 32. Anthelminthic drugs (A.G.C. Bauer). 33. Enzymes and enzyme inhibitors (M.N.G. Dukes). 34. Immunobiological preparations (S. Dittmann). 35. Blood and blood products (F.A. Ala). 36. Intravenous and parenteral infusions (P.I. Folb). 37. Drugs affecting blood coagulation and hemostasis (J. Vermylen, Ph. Vanhove and M. Verstraete). 38. Gastrointestinal drugs (M.N.G. Dukes). 39. Immunomodulating agents (J. Descotes and J.-Cl. Evreux). 40. Vitamins (H.D. Reuter). 41. Corticotrophins and corticosteriods (S. Erill). 42. Sex hormones and related compounds including oral contraceptives (K.-W. von Eickstedt). 43. Thyroid hormones, iodine and antithyroid drugs (R. Bouillon). 44. Insulin, glucagon and hypoglycemic drugs (H.M.J. Krans). 45. Miscellaneous hormones (R. Bouillon). 46. Drugs affecting lipid metabolism (I. Aursnes). 47. Cytostatics and immunosuppressive drugs (A. Stanley and G. Blackledge). 48. Radiological contrast media and radiopharmaceuticals (G. Ansell). 49. Drugs used in ocular treatment (B.C.P. Polak). 50. Drugs used in non-orthodox medicine (P.A.G.M. de Smet). 51. Miscellaneous drugs and agents (N.H. Choulis). International drug monitoring. Address list of national centres participating in the WHO drug monitoring scheme. Index of drugs. Index of side effects.